Table 4.
Chemotherapy regimen/cost for HER2 positive patients, neoadjuvant
| Taxotere, Carboplatin, Herceptin, and Perjeta (TCHP) | |||
|---|---|---|---|
| Drug | First cycle | Second cycle | Treatment course |
| Docetaxel | $1428 | $1428 | $8568 (6 doses) |
| Carboplatin | $368 | $368 | $2208 (6 doses) |
| Trastuzumab (Q3 weeks) | $19,715 (loading dose) | $15,779 (maintenance) |
$272,179 (1 loading dose + 16 maintenance doses) |
|
Pertuzumab (Q3 weeks) |
$13,504 (loading dose) | $6752 (maintenance) |
$121,536 (1 loading dose + 16 maintenance doses) |
| Total | $35,015 | $24,327 | $404,491 |